Smart Trade Insights
  • Business
  • Economy
  • Investing
  • Politics
Top Posts
Crypto Market Update: Bitcoin’s New High, Ethereum ETFs...
Top 5 Small-cap Pharma Stocks of 2025
Brien Lundin: Gold at New US$3,000 Floor, Silver...
Brunswick Exploration Consolidates Mirage Ownership
Westport Files Preliminary Short Form Base Shelf Prospectus...
Element79 Gold Corp Announces Corporate Update and Strategic...
OPINION — Goldenomics 103: Gold Protects and Performs
Editor’s Picks: Gold Tariff Threat Ends, Price Reacts...
Top 5 Canadian Mining Stocks This Week: Focus...
Bed Bath & Beyond relaunches with first store...
  • Business
  • Economy
  • Investing
  • Politics

Smart Trade Insights

Investing

Russia Restricts US Uranium Exports, Retaliating to American Ban

by admin November 19, 2024
November 19, 2024
Russia Restricts US Uranium Exports, Retaliating to American Ban

The Russian government has imposed temporary restrictions on enriched uranium exports to the US.

Announced on November 15, the move follows the US’ decision toban imports of Russian uranium.

While the US legislation went into effect in August, it allows for waivers to address potential supply disruptions through 2027. The new Russian policy introduces uncertainty during this time period.

According to the US Energy Information Administration, Russia provided 27 percent of the enriched uranium used in American reactors in 2023. Globally, the country accounts for about 44 percent of enrichment capacity.

To illustrate, Urenco — a consortium-owned company operating the only US-based enrichment facility in New Mexico — supplies only about one-third of the country’s enriched uranium.

While the restrictions from Russia don’t leave the US without recourse, as utilities typically secure uranium supply years in advance, analysts are warning that continued restrictions could pose challenges from 2025 onward.

Market responses to the news were swift. Cameco (TSX:CCO,NYSE:CCJ), a leading uranium producer, emphasized in a statement to Bloomberg the need for coordinated western action to reduce reliance on Russian nuclear fuel.

Shares of uranium companies reflected the heightened supply concerns, with Cameco’s share price jumping as much as 6.5 percent on the TSX on November 15. US-based uranium firms such as Uranium Energy (NYSEAMERICAN:UEC) and Ur-Energy (TSX:URE,NYSEAMERICAN:URG) also experienced upticks that day.

Meanwhile, shares of Centrus Energy (NYSEAMERICAN:LEU), the biggest US trader of Russian enriched uranium, fell by close to 9 percent on November 15 as investors weighed the potential impacts of the restrictions.

The company said it had not received details surrounding Russia’s decree and was assessing the implications.

Centrus also noted that it has contingency plans to mitigate near-term impacts should Russia’s state-owned uranium supplier, Tenex, face challenges fulfilling existing agreements. Centrus is one company that has received a waiver from the Biden administration to continue importing Russian uranium despite the US ban.

Constellation Energy (NASDAQ:CEG) has also received a waiver, and other requests are reportedly pending.

Russia’s actions come amid broader geopolitical tensions and follow President Vladimir Putin’s earlier call for the country to consider restricting exports of uranium, titanium and nickel in response to western sanctions.

At the same time, the US government has been actively working to rebuild its uranium enrichment capabilities. A multibillion-dollar initiative to expand these operations is underway, but progress has been slow.

Overall, the US is currently looking triple its nuclear capacity by 2050, with plans to add 200 gigawatts of new nuclear energy through reactor builds, reactivations and upgrades to existing facilities.

Securities Disclosure: I, Giann Liguid, hold no direct investment interest in any company mentioned in this article.

This post appeared first on investingnews.com

previous post
Bitcoin & Ethereum Analysis: BTC Hits High, ETH Is Steady
next post
Australian Ethics Committee Approval to Expand PD-L1 Nanobody (RAD204) Phase 1 Trial in Multiple Tumor Types

You may also like

Strong Momentum Continuing at Flicka Lake Gold and...

December 2, 2024

Hempalta Corp. Announces Financial Results for Year Ended...

December 20, 2024

Exceptional silver and cobalt assays from seaweed

February 21, 2025

Element79 Gold Corp Announces Corporate Update and Strategic...

August 16, 2025

Rick Rule, Gareth Soloway, David Morgan and More...

December 29, 2024

Tartana receives $275k Beefwood Copper Gold CEI Grant

April 15, 2025

John Feneck: Gold, Silver, Copper — 10+ Stocks...

September 11, 2024

How to Invest in Rare Earth Metals

May 6, 2025

US Admin Fast Tracks Laramide Uranium Projects, Meta...

June 4, 2025

Top 5 Canadian Mining Stocks This Week: Adyton...

October 5, 2024

    Fill Out & Get More Relevant News


    Stay ahead of the market and unlock exclusive trading insights & timely news. We value your privacy - your information is secure, and you can unsubscribe anytime. Gain an edge with hand-picked trading opportunities, stay informed with market-moving updates, and learn from expert tips & strategies.

    Recent Posts

    • Crypto Market Update: Bitcoin’s New High, Ethereum ETFs Outpace Bitcoin 5-to-1

      August 16, 2025
    • Top 5 Small-cap Pharma Stocks of 2025

      August 16, 2025
    • Brien Lundin: Gold at New US$3,000 Floor, Silver Supply Crunch Coming

      August 16, 2025
    • Brunswick Exploration Consolidates Mirage Ownership

      August 16, 2025
    • Westport Files Preliminary Short Form Base Shelf Prospectus To Replace Expired Base Shelf Prospectus

      August 16, 2025
    Promotion Image

    banner ads

    Categories

    • Business (817)
    • Economy (829)
    • Investing (2,633)
    • Politics (737)
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: smarttradeinsights.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


    Copyright © 2025 smarttradeinsights.com | All Rights Reserved